Intracranial electrode implantation produces regional neuroinflammation and memory deficits in rats

Experimental Neurology

Volumn 222, Issue 1, 2010, Pages 42-50

  Hirshler, Yafit Kuttner ^a,b   Polat, Uri ^a,c   Biegon, Anat ^a,d  

^a SHEBA MEDICAL CENTER   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d BROOKHAVEN NATIONAL LABORATORY   (United States)

Author keywords

Autoradiography; Brain injury; Deep brain stimulation; Novel Object Recognition; Peripheral Benzodiazepine Receptor; Translocator protein

Indexed keywords

BENZODIAZEPINE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN DEPTH STIMULATION; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS STRIATUM; LIGAND BINDING; MALE; MEMORY DISORDER; MENTAL PERFORMANCE; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; RECOGNITION; SUBTHALAMIC NUCLEUS;

ANALYSIS OF VARIANCE; ANIMALS; AUTORADIOGRAPHY; BRAIN; DEEP BRAIN STIMULATION; DISEASE MODELS, ANIMAL; ELECTRODES, IMPLANTED; ENCEPHALITIS; ISOQUINOLINES; MALE; MEMORY DISORDERS; NEUROPSYCHOLOGICAL TESTS; RATS; RATS, SPRAGUE-DAWLEY; RECOGNITION (PSYCHOLOGY); TIME FACTORS; TRITIUM;

EID: 77649338762     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2009.12.006     Document Type: Article

References (84)

1. Alegret M., Junque C., Valldeoriola F., Vendrell P., Pilleri M., Rumia J., Tolosa E. Effects of bilateral subthalamic stimulation on cognitive function in Parkinson disease. Arch. Neurol. 2001, 58:1223-1227.
2. Ardouin C., Pillon B., Peiffer E., Bejjani P., Limousin P., Damier P., Arnulf I., Benabid A.L., Agid Y., Pollak P. Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann. Neurol. 1999, 46:217-223.
3. Balderas I., Rodriguez-Ortiz C.J., Salgado-Tonda P., Chavez-Hurtado J., McGaugh J.L., Bermudez-Rattoni F. The consolidation of object and context recognition memory involve different regions of the temporal lobe. Learn. Mem. 2008, 15:618-624.
4. Benabid A.L., Chabardes S., Seigneuret E. Deep-brain stimulation in Parkinson's disease: long-term efficacy and safety-what happened this year?. Curr. Opin. Neurol. 2005, 18:623-630.
5. Benabid A.L., Chabardes S., Mitrofanis J., Pollak P. Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease. Lancet Neurol. 2009, 8:67-81.
6. Bermudez-Rattoni F., Okuda S., Roozendaal B., McGaugh J.L. Insular cortex is involved in consolidation of object recognition memory. Learn. Mem. 2005, 12:447-449.
7. Biegon A., Alvarado M., Budinger T.F., Grossman R., Hensley K., West M.S., Kotake Y., Ono M., Floyd R.A. Region-selective effects of neuroinflammation and antioxidant treatment on peripheral benzodiazepine receptors and NMDA receptors in the rat brain. J. Neurochem. 2002, 82:924-934.
8. Biran R., Martin D.C., Tresco P.A. Neuronal cell loss accompanies the brain tissue response to chronically implanted silicon microelectrode arrays. Exp. Neurol. 2005, 195:115-126.
9. Biran R., Martin D.C., Tresco P.A. The brain tissue response to implanted silicon microelectrode arrays is increased when the device is tethered to the skull. J. Biomed. Mater. Res. A. 2007, 82:169-178.
10. Boockvar J.A., Telfeian A., Baltuch G.H., Skolnick B., Simuni T., Stern M., Schmidt M.L., Trojanowski J.Q. Long-term deep brain stimulation in a patient with essential tremor: clinical response and postmortem correlation with stimulator termination sites in ventral thalamus. Case report. J. Neurosurg. 2000, 93:140-144.
11. Burbaud P., Vital A., Rougier A., Bouillot S., Guehl D., Cuny E., Ferrer X., Lagueny A., Bioulac B. Minimal tissue damage after stimulation of the motor thalamus in a case of chorea-acanthocytosis. Neurology 2002, 59:1982-1984.
12. Cai Z.Y., Yan Y., Sun S.Q., Zhang J., Huang L.G., Yan N., Wu F., Li J.Y. Minocycline attenuates cognitive impairment and restrains oxidative stress in the hippocampus of rats with chronic cerebral hypoperfusion. Neurosci. Bull. 2008, 24:305-313.
13. Campbell M.C., Karimi M., Weaver P.M., Wu J., Perantie D.C., Golchin N.A., Tabbal S.D., Perlmutter J.S., Hershey T. Neural correlates of STN DBS-induced cognitive variability in Parkinson disease. Neuropsychologia 2008, 46:3162-3169.
14. Carbonell W.S., Murase S., Horwitz A.F., Mandell J.W. Migration of perilesional microglia after focal brain injury and modulation by CC chemokine receptor 5: an in situ time-lapse confocal imaging study. J. Neurosci. 2005, 25:7040-7047.
15. Chou K.L., Forman M.S., Trojanowski J.Q., Hurtig H.I., Baltuch G.H. Subthalamic nucleus deep brain stimulation in a patient with levodopa-responsive multiple system atrophy. Case report. J. Neurosurg. 2004, 100:553-556.
16. Cilia R., Siri C., Marotta G., De Gaspari D., Landi A., Mariani C.B., Benti R., Isaias I.U., Vergani F., Pezzoli G., Antonini A. Brain networks underlining verbal fluency decline during STN-DBS in Parkinson's disease: an ECD-SPECT study. Parkinsonism Relat. Disord. 2007, 13:290-294.
17. Cilia R., Siri C., Marotta G., De Gaspari D., Landi A., Mariani C.B., Benti R., Isaias I.U., Vergani F., Pezzoli G., Antonini A. Brain networks underlining verbal fluency decline during STN-DBS in Parkinson's disease: an ECD-SPECT study. Parkinsonism Relat. Disord. 2007, 13:290-294.
18. Daniele A., Albanese A., Contarino M.F., Zinzi P., Barbier A., Gasparini F., Romito L.M., Bentivoglio A.R., Scerrati M. Cognitive and behavioural effects of chronic stimulation of the subthalamic nucleus in patients with Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 2003, 74:175-182.
19. De Gaspari D., Siri C., Di Gioia M., Antonini A., Isella V., Pizzolato A., Landi A., Vergani F., Gaini S.M., Appollonio I.M., Pezzoli G. Clinical correlates and cognitive underpinnings of verbal fluency impairment after chronic subthalamic stimulation in Parkinson's disease. Parkinsonism Relat. Disord. 2006, 12:289-295.
20. Del Bigio M.R. Biological reactions to cerebrospinal fluid shunt devices: a review of the cellular pathology. Neurosurgery 1998, 42:319-325. discussion 325-316.
21. Dubois A., Benavides J., Peny B., Duverger D., Fage D., Gotti B., MacKenzie E.T., Scatton B. Imaging of primary and remote ischaemic and excitotoxic brain lesions. An autoradiographic study of peripheral type benzodiazepine binding sites in the rat and cat. Brain Res. 1988, 445:77-90.
22. Dujardin K., Defebvre L., Krystkowiak P., Blond S., Destee A. Influence of chronic bilateral stimulation of the subthalamic nucleus on cognitive function in Parkinson's disease. J. Neurol. 2001, 248:603-611.
23. Ennaceur A., Delacour J. A new one-trial test for neurobiological studies of memory in rats. 1. Behavioral data. Behav. Brain Res. 1988, 31:47-59.
24. Fasano A., Mazzone P., Piano C., Quaranta D., Soleti F., Bentivoglio A.R. GPi-DBS in Huntington's disease: results on motor function and cognition in a 72-year-old case. Mov Disord. 2008, 23:1289-1292.
25. Fields J.A., Troster A.I., Woods S.P., Higginson C.I., Wilkinson S.B., Lyons K.E., Koller W.C., Pahwa R. Neuropsychological and quality of life outcomes 12 months after unilateral thalamic stimulation for essential tremor. J. Neurol. Neurosurg. Psychiatry 2003, 74:305-311.
26. Frumberg D.B., Fernando M.S., Lee D.E., Biegon A., Schiffer W.K. Metabolic and behavioral deficits following a routine surgical procedure in rats. Brain Res. 2007, 1144:209-218.
27. Funahashi S. Neuronal mechanisms of executive control by the prefrontal cortex. Neurosci. Res. 2001, 39:147-165.
28. Funkiewiez A., Ardouin C., Caputo E., Krack P., Fraix V., Klinger H., Chabardes S., Foote K., Benabid A.L., Pollak P. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 2004, 75:834-839.
29. Godefroy O. Frontal syndrome and disorders of executive functions. J. Neurol. 2003, 250:1-6.
30. Griffith R.W., Humphrey D.R. Long-term gliosis around chronically implanted platinum electrodes in the Rhesus macaque motor cortex. Neurosci. Lett. 2006, 406:81-86.
31. Grossman R., Shohami E., Alexandrovich A., Yatsiv I., Kloog Y., Biegon A. Increase in peripheral benzodiazepine receptors and loss of glutamate NMDA receptors in a mouse model of closed head injury: a quantitative autoradiographic study. NeuroImage 2003, 20:1971-1981.
32. Guilarte T.R., Kuhlmann A.C., O'Callaghan J.P., Miceli R.C. Enhanced expression of peripheral benzodiazepine receptors in trimethyltin-exposed rat brain: a biomarker of neurotoxicity. Neurotoxicology 1995, 16:441-450.
33. Haberler C., Alesch F., Mazal P.R., Pilz P., Jellinger K., Pinter M.M., Hainfellner J.A., Budka H. No tissue damage by chronic deep brain stimulation in Parkinson's disease. Ann. Neurol. 2000, 48:372-376.
34. Hauss-Wegrzyniak B., Vannucchi M.G., Wenk G.L. Behavioral and ultrastructural changes induced by chronic neuroinflammation in young rats. Brain Res. 2000, 859:157-166.
35. Henderson J.M., O'Sullivan D.J., Pell M., Fung V.S., Hely M.A., Morris J.G., Halliday G.M. Lesion of thalamic centromedian-parafascicular complex after chronic deep brain stimulation. Neurology 2001, 56:1576-1579.
36. Henderson J.M., Pell M., O'Sullivan D.J., McCusker E.A., Fung V.S., Hedges P., Halliday G.M. Postmortem analysis of bilateral subthalamic electrode implants in Parkinson's disease. Mov. Disord. 2002, 17:133-137.
37. Henry C.J., Huang Y., Wynne A.M., Godbout J.P. Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1beta and anti-inflammatory IL-10 cytokines. Brain Behav. Immun. 2009, 23:309-317.
38. Hoogman M., van de Beek D., Weisfelt M., de Gans J., Schmand B. Cognitive outcome in adults after bacterial meningitis. J. Neurol. Neurosurg. Psychiatry 2007, 78:1092-1096.
39. Imamura K., Hishikawa N., Sawada M., Nagatsu T., Yoshida M., Hashizume Y. Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains. Acta Neuropathol. 2003, 106:518-526.
40. James M.L., Selleri S., Kassiou M. Development of ligands for the peripheral benzodiazepine receptor. Curr. Med. Chem. 2006, 13:1991-2001.
41. Jarraya B., Bonnet A.M., Duyckaerts C., Houeto J.L., Cornu P., Hauw J.J., Agid Y. Parkinson's disease, subthalamic stimulation, and selection of candidates: a pathological study. Mov. Disord. 2003, 18:1517-1520.
42. Kalbe E., Voges J., Weber T., Haarer M., Baudrexel S., Klein J.C., Kessler J., Sturm V., Heiss W.D., Hilker R. Frontal FDG-PET activity correlates with cognitive outcome after STN-DBS in Parkinson disease. Neurology 2009, 72:42-49.
43. Kim W.G., Mohney R.P., Wilson B., Jeohn G.H., Liu B., Hong J.S. Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J. Neurosci. 2000, 20:6309-6316.
44. Kim Y.T., Hitchcock R.W., Bridge M.J., Tresco P.A. Chronic response of adult rat brain tissue to implants anchored to the skull. Biomaterials 2004, 25:2229-2237.
45. Kim B.J., Kim M.J., Park J.M., Lee S.H., Kim Y.J., Ryu S., Kim Y.H., Yoon B.W. Reduced neurogenesis after suppressed inflammation by minocycline in transient cerebral ischemia in rat. J. Neurol. Sci. 2009, 279:70-75.
46. Kiss Z.H., Doig-Beyaert K., Eliasziw M., Tsui J., Haffenden A., Suchowersky O. The Canadian multicentre study of deep brain stimulation for cervical dystonia. Brain 2007, 130:2879-2886.
47. Lang S. The role of peripheral benzodiazepine receptors (PBRs) in CNS pathophysiology. Curr. Med. Chem. 2002, 9:1411-1415.
48. Langdon K.D., Granter-Button S., Corbett D. Persistent behavioral impairments and neuroinflammation following global ischemia in the rat. Eur. J. Neurosci. 2008, 28:2310-2318.
49. Lenarz M., Lim H.H., Lenarz T., Reich U., Marquardt N., Klingberg M.N., Paasche G., Reuter G., Stan A.C. Auditory midbrain implant: histomorphologic effects of long-term implantation and electric stimulation of a new deep brain stimulation array. Otol. Neurotol. 2007, 28:1045-1052.
50. Leung B.K., Biran R., Underwood C.J., Tresco P.A. Characterization of microglial attachment and cytokine release on biomaterials of differing surface chemistry. Biomaterials 2008, 29:3289-3297.
51. Limousin P., Martinez-Torres I. Deep brain stimulation for Parkinson's disease. Neurotherapeutics 2008, 5:309-319.
52. Lipsman N., Neimat J.S., Lozano A.M. Deep brain stimulation for treatment-refractory obsessive-compulsive disorder: the search for a valid target. Neurosurgery 2007, 61:1-11. discussion 11-13.
53. Liu Z., Fan Y., Won S.J., Neumann M., Hu D., Zhou L., Weinstein P.R., Liu J. Chronic treatment with minocycline preserves adult new neurons and reduces functional impairment after focal cerebral ischemia. Stroke 2007, 38:146-152.
54. Maeda J., Higuchi M., Inaji M., Ji B., Haneda E., Okauchi T., Zhang M.R., Suzuki K., Suhara T. Phase-dependent roles of reactive microglia and astrocytes in nervous system injury as delineated by imaging of peripheral benzodiazepine receptor. Brain Res. 2007, 1157:100-111.
55. Marangell L.B., Martinez M., Jurdi R.A., Zboyan H. Neurostimulation therapies in depression: a review of new modalities. Acta Psychiatr. Scand. 2007, 116:174-181.
56. McConnell G.C., Schneider T.M., Owens D.J., Bellamkonda R.V. Extraction force and cortical tissue reaction of silicon microelectrode arrays implanted in the rat brain. IEEE Trans. Biomed. Eng. 2007, 54:1097-1107.
57. 3H] PK-11195 as a marker for gliosis. Acta Neurochir. (Wien) 1995, 137:207-216.
58. Mokry J., Karbanova J., Lukas J., Paleckova V., Dvorankova B. Biocompatibility of HEMA copolymers designed for treatment of CNS diseases with polymer-encapsulated cells. Biotechnol. Prog. 2000, 16:897-904.
59. Morrison C.E., Borod J.C., Perrine K., Beric A., Brin M.F., Rezai A., Kelly P., Sterio D., Germano I., Weisz D., Olanow C.W. Neuropsychological functioning following bilateral subthalamic nucleus stimulation in Parkinson's disease. Arch. Clin. Neuropsychol. 2004, 19:165-181.
60. 3H]PK 11195 binding in rat cerebral cortex following a local ischaemic lesion. J. Cereb. Blood Flow Metab. 1991, 11:314-322.
61. 3H]PK 11195 and the localisation of secondary thalamic lesions following focal ischaemia in rat motor cortex. Neurosci. Lett. 1991, 133:20-24.
62. Nielsen M.S., Bjarkam C.R., Sorensen J.C., Bojsen-Moller M., Sunde N.A., Ostergaard K. Chronic subthalamic high-frequency deep brain stimulation in Parkinson's disease-a histopathological study. Eur. J. Neurol. 2007, 14:132-138.
63. 11C]PK1195. Neurology 2000, 55:1052-1054.
64. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1998, Academic Press, San Diego. 4th Ed.
65. Pikis A., Kavaliotis J., Tsikoulas J., Andrianopoulos P., Venzon D., Manios S. Long-term sequelae of pneumococcal meningitis in children. Clin. Pediatr. (Phila.) 1996, 35:72-78.
66. Pilitsis J.G., Chu Y., Kordower J., Bergen D.C., Cochran E.J., Bakay R.A. Postmortem study of deep brain stimulation of the anterior thalamus: case report. Neurosurgery 2008, 62:E530-532. discussion E532.
67. Pillon B., Ardouin C., Damier P., Krack P., Houeto J.L., Klinger H., Bonnet A.M., Pollak P., Benabid A.L., Agid Y. Neuropsychological changes between "off" and "on" STN or GPi stimulation in Parkinson's disease. Neurology 2000, 55:411-418.
68. Raghavendra Rao V.L., Dogan A., Bowen K.K., Dempsey R.J. Traumatic brain injury leads to increased expression of peripheral-type benzodiazepine receptors, neuronal death, and activation of astrocytes and microglia in rat thalamus. Exp. Neurol. 2000, 161:102-114.
69. Saint-Cyr J.A., Trepanier L.L., Kumar R., Lozano A.M., Lang A.E. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain 2000, 123(Pt 10):2091-2108.
70. Schmidt H., Heimann B., Djukic M., Mazurek C., Fels C., Wallesch C.W., Nau R. Neuropsychological sequelae of bacterial and viral meningitis. Brain 2006, 129:333-345.
71. Schroeder U., Kuehler A., Lange K.W., Haslinger B., Tronnier V.M., Krause M., Pfister R., Boecker H., Ceballos-Baumann A.O. Subthalamic nucleus stimulation affects a frontotemporal network: a PET study. Ann. Neurol. 2003, 54:445-450.
72. Smith E.E., Jonides J. Storage and executive processes in the frontal lobes. Science 1999, 283:1657-1661.
73. Stephan C.L., Kepes J.J., SantaCruz K., Wilkinson S.B., Fegley B., Osorio I. Spectrum of clinical and histopathologic responses to intracranial electrodes: from multifocal aseptic meningitis to multifocal hypersensitivity-type meningovasculitis. Epilepsia 2001, 42:895-901.
74. Stephenson D.T., Schober D.A., Smalstig E.B., Mincy R.E., Gehlert D.R., Clemens J.A. Peripheral benzodiazepine receptors are colocalized with activated microglia following transient global forebrain ischemia in the rat. J. Neurosci. 1995, 15:5263-5274.
75. Stice P., Gilletti A., Panitch A., Muthuswamy J. Thin microelectrodes reduce GFAP expression in the implant site in rodent somatosensory cortex. J. Neural. Eng. 2007, 4:42-53.
76. Szarowski D.H., Andersen M.D., Retterer S., Spence A.J., Isaacson M., Craighead H.G., Turner J.N., Shain W. Brain responses to micro-machined silicon devices. Brain Res. 2003, 983:23-35.
77. Trepanier L.L., Kumar R., Lozano A.M., Lang A.E., Saint-Cyr J.A. Neuropsychological outcome of GPi pallidotomy and GPi or STN deep brain stimulation in Parkinson's disease. Brain Cogn. 2000, 42:324-347.
78. Turner J.N., Shain W., Szarowski D.H., Andersen M., Martins S., Isaacson M., Craighead H. Cerebral astrocyte response to micromachined silicon implants. Exp. Neurol. 1999, 156:33-49.
79. Vonck K., Boon P., Goossens L., Dedeurwaerdere S., Claeys P., Gossiaux F., Van Hese P., De Smedt T., Raedt R., Achten E., Deblaere K., Thieleman A., Vandemaele P., Thiery E., Vingerhoets G., Miatton M., Caemaert J., Van Roost D., Baert E., Michielsen G., Dewaele F., Van Laere K., Thadani V., Robertson D., Williamson P. Neurostimulation for refractory epilepsy. Acta Neurol. Belg. 2003, 103:213-217.
80. Vonck K., Boon P., Van Roost D. Anatomical and physiological basis and mechanism of action of neurostimulation for epilepsy. Acta Neurochir. Suppl. 2007, 97:321-328.
81. Willard L.B., Hauss-Wegrzyniak B., Danysz W., Wenk G.L. The cytotoxicity of chronic neuroinflammation upon basal forebrain cholinergic neurons of rats can be attenuated by glutamatergic antagonism or cyclooxygenase-2 inhibition. Exp. Brain Res. 2000, 134:58-65.
82. Witt K., Daniels C., Reiff J., Krack P., Volkmann J., Pinsker M.O., Krause M., Tronnier V., Kloss M., Schnitzler A., Wojtecki L., Botzel K., Danek A., Hilker R., Sturm V., Kupsch A., Karner E., Deuschl G. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study. Lancet Neurol. 2008, 7:605-614.
83. York M.K., Dulay M., Macias A., Levin H.S., Grossman R., Simpson R., Jankovic J. Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 2008, 79:789-795.
84. Yrjanheikki J., Keinanen R., Pellikka M., Hokfelt T., Koistinaho J. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:15769-15774.